Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vincristine infusion. A phase I study.

Literature DB >> 317027

Vincristine infusion. A phase I study.

W Weber, G A Nagel, E Nagel-Studer, R Albrecht.

Abstract

Entities: Chemical

Mesh：

Substances：
Vincristine
Esterases

Year: 1979 PMID： 317027 DOI： 10.1007/bf00254420

Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN： 0344-5704 Impact factor: 3.333

× No keyword cloud information.

31 in total

1. The pharmacokinetics of [3H]-vincristine in man.

Authors: R A Bender; M C Castle; D A Margileth; V T Oliverio
Journal: Clin Pharmacol Ther Date: 1977-10 Impact factor: 6.875

2. Pharmacokinetics of vindesine and vincristine in humans.

Authors: R J Owellen; M A Root; F O Hains
Journal: Cancer Res Date: 1977-08 Impact factor: 12.701

3. Acid esterase in human lymphoid cells and leukaemic blasts: a marker for T lymphocytes.

Authors: J Kulenkampff; G Janossy; M F Greaves
Journal: Br J Haematol Date: 1977-06 Impact factor: 6.998

4. Vincristine treatment of advanced cancer: a cooperative study of 392 cases.

Authors: J F Holland; C Scharlau; S Gailani; M J Krant; K B Olson; J Horton; B I Shnider; J J Lynch; A Owens; P P Carbone; J Colsky; D Grob; S P Miller; T C Hall
Journal: Cancer Res Date: 1973-06 Impact factor: 12.701

5. Isolation of normal T cells in chronic lymphatic leukaemia.

Authors: J Wybran; S Chantler; H H Fudenberg
Journal: Lancet Date: 1973-01-20 Impact factor: 79.321

6. Caerulein treatment for paralytic ileus.

Authors: A Agosti; G Bertaccini; R Paulucci; E Zanella
Journal: Lancet Date: 1971-02-20 Impact factor: 79.321

7. Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells.

Authors: H Madoc-Jones; F Mauro
Journal: J Cell Physiol Date: 1968-12 Impact factor: 6.384

8. More on vincristine in treatment of ITP.

Authors: Y Tangün; T Atamer
Journal: N Engl J Med Date: 1977-10-20 Impact factor: 91.245

Review 9. Identifying and enumerating human T and B lymphocytes. A review of techniques, problems, and progress in clinical studies.

Authors: J M Dwyer
Journal: Prog Allergy Date: 1976

Vincristine infusion. A phase I study.

1. The pharmacokinetics of [3H]-vincristine in man.

2. Pharmacokinetics of vindesine and vincristine in humans.

3. Acid esterase in human lymphoid cells and leukaemic blasts: a marker for T lymphocytes.

4. Vincristine treatment of advanced cancer: a cooperative study of 392 cases.

5. Isolation of normal T cells in chronic lymphatic leukaemia.

6. Caerulein treatment for paralytic ileus.

7. Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells.

8. More on vincristine in treatment of ITP.

Review 9. Identifying and enumerating human T and B lymphocytes. A review of techniques, problems, and progress in clinical studies.

Review 10. Immunodeficiency in cancer and the importance of immune evaluation of the cancer patient.

1. Treatment of vincristine-induced ileus with sincalide, a cholecystokinin analog.

2. An investigation of the mouse as a model for vincristine toxicity.

Review 3. Clinical pharmacokinetics of commonly used anticancer drugs.

4. Phase II trial of vincristine infusion in acute leukemia.